CA2357306A1 - Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists - Google Patents

Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists Download PDF

Info

Publication number
CA2357306A1
CA2357306A1 CA002357306A CA2357306A CA2357306A1 CA 2357306 A1 CA2357306 A1 CA 2357306A1 CA 002357306 A CA002357306 A CA 002357306A CA 2357306 A CA2357306 A CA 2357306A CA 2357306 A1 CA2357306 A1 CA 2357306A1
Authority
CA
Canada
Prior art keywords
hydrogen
lower alkyl
halogen
compound
alkylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002357306A
Other languages
English (en)
French (fr)
Inventor
Corinne Elizabeth Augelli-Szafran
Thomas M. Boehme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CA2357306A1 publication Critical patent/CA2357306A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002357306A 2000-09-22 2001-09-14 Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists Abandoned CA2357306A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23482600P 2000-09-22 2000-09-22
US60/234,826 2000-09-22

Publications (1)

Publication Number Publication Date
CA2357306A1 true CA2357306A1 (en) 2002-03-22

Family

ID=22882987

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002357306A Abandoned CA2357306A1 (en) 2000-09-22 2001-09-14 Fused ring system containing indole as m4 selective aza-anthracene muscarinic receptor antagonists

Country Status (6)

Country Link
US (1) US6500837B2 (cg-RX-API-DMAC7.html)
EP (1) EP1191027A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002114786A (cg-RX-API-DMAC7.html)
BR (1) BR0104169A (cg-RX-API-DMAC7.html)
CA (1) CA2357306A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA01009550A (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072549A1 (en) * 2001-03-12 2002-09-19 Millennium Pharmaceuticals, Inc. Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
MX2021011588A (es) * 2019-03-25 2021-12-15 Cold Spring Harbor Laboratory Antagonistas del receptor muscarinico de acetilcolina subtipo 4 en el tratamiento de la anemia.

Also Published As

Publication number Publication date
BR0104169A (pt) 2002-07-09
US6500837B2 (en) 2002-12-31
EP1191027A1 (en) 2002-03-27
JP2002114786A (ja) 2002-04-16
US20020068752A1 (en) 2002-06-06
MXPA01009550A (es) 2002-04-12

Similar Documents

Publication Publication Date Title
EP0319429B1 (en) 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
NO162615B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4,5-tetrahydrobenz (c,d) indoler.
JPH04334367A (ja) 置換された1,2,3,4−テトラヒドロシクロペント〔b〕インドール、1,2,3,3a,4,8a−ヘキサヒドロシクロペント〔b〕インドールおよび関連化合物
KR920003927B1 (ko) 헤테로사이클릭구아니딘 5ht_3 길항물질
KR20040013126A (ko) 녹내장 및 근시 치료용 벤조 [g] 퀴놀린 유도체
KR101027977B1 (ko) 퀴놀린 유도체
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
US6500837B2 (en) Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists
EP1053235A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
Eda et al. Novel Potassium-Channel Openers: Preparation and Pharmacological Evaluation of Racemic and Optically Active N-(6-Amino-3-pyridyl)-N'-bicycloalkyl-N''-cyanoguanidine Derivatives
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
CA2165618C (fr) Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6057334A (en) Benzo[g]quinoline derivatives
JPH0573754B2 (cg-RX-API-DMAC7.html)
IE66726B1 (en) 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives a process for their preparation and pharmaceutical compositions containing them
AU651171B2 (en) Oxazinobenzazole compounds
EP0118566B1 (en) INDENO[1,2-b]PYRROLE DERIVATIVES
JPH10505332A (ja) アシルイミダゾピリジン
EP1282625B1 (en) Benzoxazines for use in the treatment of parkinson's disease
JPH10505330A (ja) ハロゲンイミダゾピリジン
JPH05310749A (ja) アザビシクロ誘導体
CN113651767A (zh) 一种苯并异噁唑类杂环化合物及其制备方法和应用
WO2020210246A1 (en) Heterocyclic compounds as rsv inhibitors
KR20090096749A (ko) 트리아자벤조〔a〕나프토〔2,1,8­cde〕아줄렌 유도체, 이의 제조방법 및 이를 함유하는 약제 조성물
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued